Skip to content
10-K

Annual Report

JOHNSON & JOHNSON JNJ

0000200406-25-000038

← back to feed
Filed
Feb 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 6, 2025 2.41B sh
Long Term Debt FY 2024 · Dec 31, 2023 $25.88B
Short Term Debt FY 2024 · Dec 31, 2023 $3.45B
Cash And Equivalents FY 2024 · Dec 31, 2023 $21.86B
Current Liabilities FY 2024 · Dec 31, 2023 $46.28B
Total Liabilities FY 2024 · Dec 31, 2023 $98.78B
Current Assets FY 2024 · Dec 31, 2023 $53.5B
Total Assets FY 2024 · Dec 31, 2023 $167.56B
Shares Diluted FY 2024 · Jan 1, 2023 2.66B sh
Stock Repurchased FY 2024 · Jan 1, 2023 $6.04B
Capex FY 2024 · Jan 1, 2023 $4.01B
Operating Cash Flow FY 2024 · Jan 1, 2023 $21.19B
Eps Diluted FY 2024 · Jan 1, 2023 $6.73
Eps Basic FY 2024 · Jan 1, 2023 $6.83
Sga Expense restated FY 2024 · Jan 1, 2023 $20.25B
Rd Expense FY 2024 · Jan 1, 2023 $0
Net Income FY 2024 · Jan 1, 2023 $17.94B
Gross Profit restated FY 2024 · Jan 1, 2023 $55.39B
Cost Of Revenue restated FY 2024 · Jan 1, 2023 $24.6B
Revenue restated FY 2024 · Jan 1, 2023 $79.99B